Head to Head Comparison: Nexeon Medsystems (OTCMKTS:NXNN) and QT Imaging (NASDAQ:QTI)

QT Imaging (NASDAQ:QTI) and Nexeon Medsystems (OTCMKTS:NXNN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Institutional & Insider Ownership

24.2% of QT Imaging shares are held by institutional investors. 28.8% of QT Imaging shares are held by company insiders. Comparatively, 61.2% of Nexeon Medsystems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares QT Imaging and Nexeon Medsystems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
QT Imaging	-111.40%	N/A	-144.16%
Nexeon Medsystems	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for QT Imaging and Nexeon Medsystems, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1	0	1	0	2.00
Nexeon Medsystems	0	0	0	0	0.00

Given Nexeon Medsystems’ higher probable upside, analysts clearly believe Nexeon Medsystems is more favorable than QT Imaging.

Valuation & Earnings

This table compares QT Imaging and Nexeon Medsystems”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.92 million	3.47	-$21.08 million	($2.19)	-2.51
Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A

Nexeon Medsystems has lower revenue, but higher earnings than QT Imaging.

Volatility & Risk

QT Imaging has a beta of -0.1, suggesting that its stock price is 110% less volatile than the S&P 500. Comparatively, Nexeon Medsystems has a beta of 6.98, suggesting that its stock price is 598% more volatile than the S&P 500.

Summary

Nexeon Medsystems beats QT Imaging on 5 of the 9 factors compared between the two stocks.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

About Nexeon Medsystems

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.